Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 open-label study of S-6810 in mycosis fungoides or Sezary syndrome
jRCT2080221783Phase 2
- Sponsor
- Shionogi & Co., Ltd.
- Start
- May 2012
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of denileukin diftitox in mycosis fungoides (MF) and Sézary syndrome (SS), sponsored by Shionogi & Co., Ltd.
02
Drugs
denileukin diftitox
03
Conditions
mycosis fungoides (MF)Sézary syndrome (SS)
Beyond the preview
Go deeper on jRCT2080221783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221783.